Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06506344 · ClinicalTrials.gov registry record · NA
Syncing Screening and Services for Suicide Prevention Across Health and Justice Systems
A NA study of Suicide Prevention, sponsored by Henry Ford Health System.
- Recruiting
- Registry status
- NA
- Development phase
- 5,250
- Enrollment target
- 2
- Study locations
NCT06506344: Recruiting NA study of Suicide Prevention, sponsored by Henry Ford Health System.
NCT06506344 is a NA study of Suicide Prevention that is actively recruiting participants, run by Henry Ford Health System. The registered enrollment target is 5,250 participants, above the 703-participant average among 21 other Suicide Prevention trials with a reported enrollment target (647% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06506344, a NA study of Suicide Prevention, is actively recruiting participants, sponsored by Henry Ford Health System.
- RECRUITING
- Registry status
- NA
- Development phase
- 5,250 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study aims to harmonize jail release record data with electronic health record data in order to connect patients to an evidence-based suicide prevention and clinical care pathway upon jail release.
Primary Outcome
Nonfatal medically treated suicide attempts will be identified using diagnosis and encounter codes from all inpatient, outpatient, and emergency department encounters recorded in the EHR (for services delivered by participating systems) or claims (for outside services). All suicide deaths will be identified via linkage to regularly updated state mortality data and the National Death Index (NDI). Suicide deaths will be identified using ICD-10 codes indicating definite or possible self-inflicted i
Conditions Studied
Interventions
- BEHAVIORAL 5S Trial
Study Locations (2)
Michigan
- Henry Ford Health - Detroit
Minnesota
- HealthPartners Institute - Bloomington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,250 participants |
| Start Date | 2024-06-24 |
| Est. Completion | 2027-07 |
| Phase | NA |
What NCT06506344 shows while recruiting
NCT06506344 is an interventional study that assigns participants to a tested intervention. Its 5,250 participants enrollment target places it among the larger protocols in the corpus, above the 703-participant average among 21 other Suicide Prevention trials with a reported enrollment target (647% higher).
The record links to 1 condition, with Suicide Prevention appearing as the primary indexed condition, and to 1 intervention - of which 5S Trial is the first listed.
NCT06506344 reports a single indexed study location in Michigan, Minnesota.
Frequently Asked Questions
What is clinical trial NCT06506344 about?
NCT06506344 is a clinical study titled "Syncing Screening and Services for Suicide Prevention Across Health and Justice Systems". This study aims to harmonize jail release record data with electronic health record data in order to connect patients to an evidence-based suicide prevention and clinical care pathway upon jail release.
What is the current status of trial NCT06506344?
This trial is currently recruiting. It is a NA study. The enrollment target is 5,250 participants. The study started on 2024-06-24. Estimated completion is 2027-07.
What conditions does trial NCT06506344 study?
This clinical trial studies the following conditions: Suicide Prevention.
What interventions are being tested in trial NCT06506344?
The interventions under investigation include: 5S Trial (BEHAVIORAL).
Who is sponsoring clinical trial NCT06506344?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06506344 being conducted?
This trial has 2 study locations across Michigan, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide Prevention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06506344's enrollment target sits among peer trials
5,250 1st of 21 higher than 21 of 21 other Suicide Prevention trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicide Prevention trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Controlled Effectiveness Trial of VA S.A.V.E.
RECRUITING · NA
-
Project Safe Guard-Trauma
RECRUITING · NA
-
Virtual Reality Lethal Means Safety Training
RECRUITING · NA
-
Efficacy-Implementation Study for PC CARES in Rural Alaska
RECRUITING · NA
-
Suicide Prevention After Community Care Discharge
RECRUITING · NA
-
HAVEN-Connect Youth Suicide Prevention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05989308 · 5,200 participants · NA
MyChart Proxy Outreach to Parents (MyPOP)
- NCT06008197 · 5,200 participants · Phase 3
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- NCT05135403 · 5,179 participants
ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)
- NCT05373771 · 5,328 participants · NA
Sickle Cell Improvement: Enhancing Care in the Emergency Department
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI